Physician profile
Xi Na
NPI 1700049269
$1,865.31
in general payments reported to CMS, 2019-2025
18 companies · $50.02 in 2025
The $50.02 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,264 · 2020: $201 · 2021: $80.53 · 2022: $116 · 2023: $51.99 · 2024: $101 · 2025: $50.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $142 · Education: $61.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $141.63 |
| Education | $61.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $678.04 | 2019-2024 | |
| Pfizer INC. | $247.07 | 2019-2025 | |
| Janssen Biotech, INC. | $241.97 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $131.13 | 2019 | |
| Ucb, INC. | $105.57 | 2019 | |
| Ferring Pharmaceuticals INC. | $76.72 | 2019-2020 | |
| Celgene Corporation | $68.92 | 2021-2024 | Zeposia |
| Braintree Laboratories, INC. | $56.83 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $48.61 | 2019 | |
| Merck Sharp & Dohme LLC | $32.45 | 2019 | |
| Ironwood Pharmaceuticals, INC | $30.75 | 2019 | |
| Endo Pharmaceuticals INC. | $30.13 | 2019 | |
| Intercept Pharmaceuticals, INC. | $25.52 | 2021 | |
| Concordia Pharmaceuticals INC. | $21.66 | 2019 | |
| Shionogi INC | $21.46 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $19.32 | 2019 | |
| Allergan, INC. | $15.33 | 2019 | |
| Shire North American Group INC | $13.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xi Na listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.